Nestlé is entering the weight-loss market with the launch of its new protein shots in the United States, which are specifically developed for those taking weight-loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
This initiative is the company's latest attempt to capitalize on rising demand for weight-loss medications in an increasing obesity drug industry.
The newly released Boost Pre-Meal Hunger Support injections are designed to decrease appetite and promote a feeling of fullness. Nestlé believes that these drinks can trigger a natural response in the body that is similar to the effects of GLP-1, a hormone that suppresses hunger and increases satiety.
The shots are indicated for intake up to 30 minutes before meals, in accordance with the timing of GLP-1 injections.
Each shot has 10g of whey protein, 45 calories, 1g of sugar, and is fat-free.
The product is priced at around $10.99 per pack of four and is available on platforms such as Amazon and select CVS shops.
The weight-loss medicine market is expected to reach $150 billion per year within the next decade, creating a profitable potential for food makers.
Nestlé's debut into this category follows the launch of a line of frozen pizzas and protein-enriched pastas designed for people using weight-loss drugs.
CMI Research: Key Weight Loss and Obesity Management Market Insights
Coherent Market Insights (CMI) projects that the weight loss and obesity management market will exhibit a compound annual growth rate (CAGR) of 7.9% from 2023 to 2030 due to increasing launch of weight loss and obesity management programs. The market, which was valued at approximately US$ 225.66 billion in 2023, is forecasted to boost over the forecast period.
The rising number of obese people around the world is one of the primary drivers of the weight reduction and obesity management market.
Analyst Opinion: Strategic Role in Weight Loss and Obesity Management Market Growth
According to management consultant Komal Dighe, the worldwide weight loss and obesity management market would be driven by an increase in the number of weight loss and obesity management programs launched during the projected period.
Conclusion: Business Takeaways and Pivotal Role
Businesses that specialize in weight loss and obesity management play an important role in tackling global health issues. They can fulfill expanding demand by providing individualized, sustainable solutions that make use of technology. To have a long-lasting influence, success requires integrating medical expertise, focusing on long-term results, and responding to various customer needs.